Subclonal heterogeneity sheds light on the transformation trajectory in IGLV3-21R110 chronic lymphocytic leukemia

Subclonal heterogeneity sheds light on the transformation trajectory in IGLV3-21R110 chronic lymphocytic leukemia

Bibliographic Details
Main Authors:	Lisa Paschold, Donjete Simnica, Ramon Benitez Brito, Tianjiao Zhang, Christoph Schultheiß, Christine Dierks, Mascha Binder
Format:	Article
Language:	English
Published:	Nature Publishing Group 2022-03-01
Series:	Blood Cancer Journal
Online Access:	https://doi.org/10.1038/s41408-022-00650-4

Similar Items

P621: SUBCLONAL EVOLUTIONARY TRAJECTORIES IN IGLV3-21R110 CHRONIC LYMPHOCYTIC LEUKEMIA
by: L. Paschold, et al.
Published: (2022-06-01)

Mutation-specific CAR T cells as precision therapy for IGLV3-21R110 expressing high-risk chronic lymphocytic leukemia
by: Florian Märkl, et al.
Published: (2024-02-01)

P609: CLINICOBIOLOGICAL CHARACTERISTICS AND TREATMENT EFFICACY OF NOVEL AGENTS IN CHRONIC LYMPHOCYTIC LEUKEMIA WITH IGLV3-21R110
by: P. Hengeveld, et al.
Published: (2022-06-01)

Maturation trajectories and transcriptional landscape of plasmablasts and autoreactive B cells in COVID-19
by: Christoph Schultheiß, et al.
Published: (2021-11-01)

PD-L1 Amino Acid Position 88 Represents a Hotspot for PD-L1 Stability With Relevance for PD-L1 Inhibition
by: Luise Victoria Claaß, et al.
Published: (2022-07-01)

Targeting the Mutational Landscape of Bystander Cells: Drug-Promoted Blood Cancer From High-Prevalence Pre-neoplasias in Patients on BRAF Inhibitors
by: Donjete Simnica, et al.
Published: (2020-09-01)

Rapid Hypermutation B Cell Trajectory Recruits Previously Primed B Cells Upon Third SARS-Cov-2 mRNA Vaccination
by: Lisa Paschold, et al.
Published: (2022-05-01)

Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia
by: Landau, Dan A., et al.
Published: (2014)

P631: A PCR-BASED ASSAY FOR IGLV3-21R110 SCREENING CONFIRMS ITS PROGNOSTIC VALUE IN AN INDEPENDENT COHORT OF 613 PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA.
by: C. Syrykh, et al.
Published: (2022-06-01)

The light chain IgLV3-21 defines a new poor prognostic subgroup in chronic lymphocytic leukemia: Results of a multicenter study
by: Stamatopoulos, B, et al.
Published: (2018)

LINFOMA/LEUKEMIA DE BURKITT APRESENTANDO SUBCLONES
by: Patrícia Gama, et al.
Published: (2023-04-01)

Circulating Tumor DNA in Gastric and Gastroesophageal Junction Cancer
by: Lisa Paschold, et al.
Published: (2022-02-01)

Landscape of T‐cell repertoires with public COVID‐19‐associated T‐cell receptors in pre‐pandemic risk cohorts
by: Donjete Simnica, et al.
Published: (2021-01-01)

Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.
by: Knight, S, et al.
Published: (2012)

Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.
by: Knight, S, et al.
Published: (2012)

High-Throughput Immunogenetics Reveals a Lack of Physiological T Cell Clusters in Patients With Autoimmune Cytopenias
by: Donjete Simnica, et al.
Published: (2019-08-01)

P323: UNCOVERING SUBCLONAL METABOLIC VULNERABILITIES IN ACUTE LYMPHOBLASTIC LEUKEMIA AT SINGLE CELL RESOLUTION
by: Maximilian Mönnig, et al.
Published: (2023-08-01)

Principles of reconstructing the subclonal architecture of cancers
by: Dentro, S, et al.
Published: (2017)

Subclonal heterogeneity and evolution in breast cancer
by: Ioanna Mavrommati, et al.
Published: (2021-12-01)

Progression of adult T‐cell leukemia/lymphoma from smoldering to acute type due to branched subclonal evolution
by: Koji Jimbo, et al.
Published: (2023-11-01)

Pursuing dynamics of minimal residual leukemic subclones in relapsed and refractory acute myeloid leukemia during conventional therapy
by: Dongchan Kim, et al.
Published: (2024-04-01)

How subclonal modeling is changing the metastatic paradigm
by: Macintyre, G, et al.
Published: (2016)

Relapse-Fated Subclones: Finding the Needle in the Haystack
by: Melania Tesio
Published: (2020-06-01)

Exploring the Eco-Evolutionary Dynamics of Tumor Subclones
by: Theodoros Rampias
Published: (2020-11-01)

Combating subclonal evolution of resistant cancer phenotypes
by: Samuel W. Brady, et al.
Published: (2017-11-01)

Stereotypical chronic lymphocytic leukemia B-cell receptors recognize survival promoting antigens on stromal cells.
by: Mascha Binder, et al.
Published: (2010-01-01)

First-line treatment of unresectable or metastatic HER2 positive esophagogastric adenocarcinoma: liquid biomarker analysis of the phase 2 INTEGA trial
by: Alexander Stein, et al.
Published: (2023-06-01)

The MEC1 and MEC2 lines represent two CLL subclones in different stages of progression towards prolymphocytic leukemia.
by: Eahsan Rasul, et al.
Published: (2014-01-01)

Generating subclones from large-insert genomic clones.
by: Monaco, A, et al.
Published: (2001)

Subcloning and purification of beta glucosidase from anoxybacillus species /
by: Lee, Li Sin, 1990- 605207, et al.
Published: (2014)

Subcloning and purification of beta glucosidase from anoxybacillus species /
by: Lee, Li Sin, 1990- author
Published: (2014)

On measuring selection in cancer from subclonal mutation frequencies.
by: Ivana Bozic, et al.
Published: (2019-09-01)

Quantifying the influence of mutation detection on tumour subclonal reconstruction
by: Lydia Y. Liu, et al.
Published: (2020-12-01)

Association between EcoRI fragment-length polymorphism of the immunoglobulin lambda variable 8 (IGLV8) gene family with rheumatoid arthritis and systemic lupus erythematosus
by: Queiroz R.G.P., et al.
Published: (2001-01-01)

Ebola virus shed glycoprotein is toxic to human T, B, and natural killer lymphocytes
by: Luis J. Perez-Valencia, et al.
Published: (2023-08-01)

Neisseria gonorrhoeae FC428 Subclone, Vietnam, 2019-2020
by: Trinh, TM, et al.
Published: (2022)

Pre-existing subclones determine radioresistance in rectal cancer organoids
by: Daan Andel, et al.
Published: (2024-02-01)

KDM5B predicts temozolomide-resistant subclones in glioblastoma
by: Vivien Ullrich, et al.
Published: (2024-01-01)

Methylase-assisted subcloning for high throughput BioBrick assembly
by: Ichiro Matsumura
Published: (2020-09-01)

Cancer Subclonal Genetic Architecture as a Key to Personalized Medicine
by: Alnawaz Rehemtulla
Published: (2013-12-01)